India
Cancer Drug Prices Slashed by Up to 96% as New MRPs Take Effect Across India
Revised prices for 1,364 anti-cancer drug formulations took effect on November 9 after the pricing regulator capped trade margins at 30%, with the government estimating annual savings of ₹3,540 crore for patients.